English
This article is from International Journal of Cardiology , volume 174 . Abstract Background: The phagocytic enzyme myeloperoxidase (MPO) acts as a front-line defender against microorganisms. However, increased MPO levels have been found to be associated with complex and calcified atherosclerotic lesions and incident cardiovascular disease. Therefore, this study aimed to investigate a predictive role of MPO, a biomarker of inflammation and oxidative stress, for total and cardiovascular mortality in patients referred to coronary angiography. Methods and results: MPO plasma concentrations along with eight MPO polymorphisms were determined in 3036 participants of the Ludwigshafen Risk and Cardiovascular Health study (median follow-up 7.75 years). MPO concentrations were positively associated with age, diabetes, smoking, markers of systemic inflammation (interleukin-6, fibrinogen, C-reactive protein, serum amyloid A) and vascular damage (vascular cellular adhesion molecule-1 and intercellular adhesion molecule-1) but negatively associated with HDL-cholesterol and apolipoprotein A-I. After adjustment for cardiovascular risk factors MPO concentrations in the highest versus the lowest quar
Sign in with your free account to read, download EPUBs or listen.
Ebook · Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--The LURIC study. · Scharnagl, Hubert, Kleber, Marcus E., Genser, Bernd, Kickmaier, Sandra, Renner, Wilfried, Weihrauch, Gisela, Grammer, Tanja, Rossmann, Christine · Internet Archive